Drug factory · FDA FEI 3002807203
DSM Nutritional Products AG Zweigniederlassung Werk Sisseln
Hauptstrasse 4, Sisseln AG, Switzerland
Problems found, fixed voluntarily at FDA's last inspection, May 16, 2025.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
5 drug inspections on record since 2012: 4 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Phytonadione | Makes the active ingredient | Cipla USA., Inc. | 69097-003 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| May 16, 2025 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 19, 2019 | No problems found | Drug Quality Assurance | — |
| Jan 25, 2018 | No problems found | Drug Quality Assurance | — |
| Jan 15, 2016 | No problems found | Drug Quality Assurance | — |
| May 24, 2012 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.